Data protection Impressum

Life sciences

Barcelona-based STE Pharmaceuticals plans to convert the former Analytecon plant in Couvet, in the canton of Neuchâtel, into a production site and an R&D department, with completion targeted for 2032.

Catalan pharmaceutical group STE Pharmaceuticals to establish production and R&D in Couvet

3 November 2026

Brazilian encapsulation specialist Nanovetores, backed by Givaudan, is setting up its new headquarters and a production plant in the canton of Bern to serve its European clients more quickly.

Why Nanovetores chose Bern for its new headquarters and production plant

3 November 2026

Built with partners in Zurich and Geneva, spora is a spatial proteomics atlas that EPFL describes as the world's largest freely available collection of its kind, designed to speed up AI research on how diseases develop.

EPFL releases a free tissue atlas to help AI understand cancer

2 November 2026

Alcon, the eye care company headquartered in Geneva, has acquired US biotech Neurotech Pharmaceuticals for USD 550 million in cash, plus potential additional payments tied to milestones.

Alcon has acquired Neurotech for USD 550 million

26 October 2026

Distalmotion, a medtech company based in Lausanne, has secured a senior secured term loan facility of up to USD 70 million from Perceptive Advisors to accelerate the US expansion of its DEXTER robotic surgery system in ambulatory surgery centers.

Distalmotion secures up to USD 70 million to expand its DEXTER surgical robot in the US

26 October 2026

Orbis Medicines, a drug discovery company with operations in Lausanne and Copenhagen, has entered a multi-target collaboration with Novo Nordisk worth up to USD 1.4 billion to develop oral macrocycle drugs for cardiometabolic diseases.

Orbis Medicines and Novo Nordisk partner in a deal worth up to USD 1.4 billion

21 October 2026

Biopôle-based Legacy Healthcare has received Breakthrough Therapy designation from the U.S. FDA for Cinainu, a topical botanical drug for moderate-to-severe alopecia areata in patients aged two and older.

Legacy Healthcare’s botanical treatment receives FDA Breakthrough Therapy designation

21 October 2026

The sitem-insel School in Bern is accepting applications until 15 December 2026 for two continuing education programs of the University of Bern: a CAS in Biomedical Entrepreneurship and a CAS in Artificial Intelligence in Digital Medicine.

From biomedical start-up to clinical AI: sitem-insel opens two University of Bern CAS programs

19 October 2026

WuXi AppTec has opened a new pharmaceutical production line at its site in Couvet, in the canton of Neuchâtel. The USD 100 million investment is part of a broader project to make the site a main production center in Europe for the group.

WuXi AppTec inaugurates a USD 100 million spray-drying line in Couvet

7 October 2026

A new study by BAK Economics shows that the life sciences sector generates CHF 20.6 billion in direct value added in Western Switzerland, and CHF 28.3 billion once its ripple effects across the regional economy are taken into account.

Life sciences generate CHF 28.3 billion in direct value in Western Switzerland

6 October 2026

1 2 3 4 5 … 31